SH
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF · OTC
$0.47 +0.00% (+$0.00)
Market Cap ¥4.61B
P/E Ratio 22.73x
Div. Yield 4.51%
ROE 1.67%
Bulios Fair Price
$0.56
19.3% upside
Current Price
$0.47
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SHEZF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
8/9Valuation
78 /100
Cheap P/B 0.39x
P/S 0.88x
P/E 22.73x
Growth
3 /100
Declining Rev. growth 8.53%
Book val. growth 0.76%
EPS growth 21.70%
Profitability
53 /100
Moderate FCF margin 26.70%
Op. margin 3.93%
Gross margin 33.33%
Quality
8 /100
Poor Asset turnover 0.32x
ROA 1.24%
ROIC 1.14%
Debt
76 /100
Low Net debt/EBITDA 2.73x
Int. coverage 7.84x
Debt/Equity 0.24x
Stability
35 /100
Moderate Profitable years 2
EPS volatility 195.50%
Beta 0.31x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SHEZF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Li Li
Employees
1,926
Headquarters
Shenzhen